Zhengye Biotechnology Holding Limited (ZYBT)
ZYBT trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.48
-12.43% on the day
Market cap
$70.1M
Micro cap
Revenue · 2025
$16.6M
-34.8% on 2024
Net income · 2025
-$10.0M
-60.0% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | ZYBT on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | China |
| IPO year | 2025 |
| SEC CIK | 0001975641 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | F4 |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $16.6M |
| Net income | -$10.0M |
| Operating income | -$10.1M |
| Net margin | -60.0% |
| Operating margin | -60.6% |
| Revenue growth | -34.8% |
| Cash | Not in SEC XBRL data |
| Total assets | $62.4M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 4.2× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS | 424B4 | 2025-01-07 |
| Latest annual report ANNUAL REPORT | 20-F | 2026-04-28 |
| Latest quarterly / interim REPORT OF FOREIGN PRIVATE ISSUER | 6-K | 2026-08-06 |
Source: SEC EDGAR submissions feed, 61 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| HYFT | MindWalk Holdings Corp. | $1.48 | +5.71% | $69.7M |
| NMAD | Nomad Power Solutions Inc. | $4.28 | +2.64% | $68.9M |
| MAIA | MAIA Biotechnology Inc. | $1.16 | -1.70% | $71.6M |
| CING | Cingulate Inc. | $4.72 | -2.48% | $68.6M |
| OSTX | OS Therapies Incorporated | $1.45 | -7.05% | $67.4M |
| SPRO | Spero Therapeutics Inc. | $1.15 | -2.54% | $67.0M |
| CTOR | Citius Oncology Inc. | $0.7920 | -2.54% | $73.6M |
| MNOV | Medicinova Inc | $1.50 | -2.60% | $73.8M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier